The fraction of cells in the sub-G1 phase was lower in Caki/c-FLIPL-expressing cells compared to Caki/vector cells after treatment with TRAIL, TG, and Dox, indicating that the restoration of c-FLIPL counteracted the effects of miR-708 on the sensitivity of renal cancer cells to apoptotic stimuli (Fig. 4E). Here, TNFSF10 is linked to renal carcinoma.